Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;272(5):757-771.
doi: 10.1007/s00406-021-01351-y. Epub 2021 Nov 25.

Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders

Affiliations

Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders

Claudia Bartels et al. Eur Arch Psychiatry Clin Neurosci. 2022 Aug.

Abstract

While the COVID-19 pandemic continues, patients with pre-existing mental disorders are increasingly recognized as a risk group for adverse outcomes. However, data are conflicting and cover only short time spans so far. Here, we investigate the medium-term and peri-lockdown-related changes of mental health outcomes in such patients in a longitudinal study. A cohort of 159 patients comprising all major mental disorders (ICD-10 F0-F9) were interviewed twice with the Goettingen psychosocial Burden and Symptom Inventory (Goe-BSI) to evaluate psychosocial burden, psychiatric symptoms and resilience at the end of the first (April/May 2020) and the second lockdown in Germany (November/December 2020). For the primary outcome "psychosocial burden" ratings also comprised retrospective pre-pandemic (early 2020) and very early states during the pandemic (March 2020). For all diagnostic groups, psychosocial burden varied significantly over time (p < 0.001) with an increase from the pre-pandemic to the initial phase (p < 0.001), followed by a steady decrease across both lockdowns, normalizing in November/December 2020. Female gender, high adjustment disorder symptom load at baseline and psychiatric comorbidities were risk factors for higher levels and an unfavorable course of psychosocial burden. Most psychiatric symptoms changed minimally, while resilience decreased over time (p = 0.044 and p = 0.037). The longitudinal course of psychosocial burden indicates an initial stress response, followed by a return to pre-pandemic levels even under recurrent lockdown conditions, mimicking symptoms of an adjustment disorder. Strategies for proactive, specific and continuous treatment have to address resilience capacities before their depletion in the pandemic aftermath, especially for patients with additional risk factors.

Keywords: Adjustment disorder; Coronavirus; Mental health; Psychosocial stress; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

All authors report no financial relationships with commercial interests related to this article. Beyond that, CB receives honoraria as a diagnostic consultant for Boehringer Ingelheim and received honoria for lectures from Roche. CB, PH, MAH, KR, and MB receive funding from the German Alzheimer Association. US is consultant for Boehringer Ingelheim, Germany. BHS holds grants from the German Research Foundation (DFG), as well as the European Union and the State of Saxony-Anhalt (Research Alliance “Autonomy in Old Age”). JW is supported by an Ilídio Pinho professorship, iBiMED (UIDB/04501/2020) at the University of Aveiro, Portugal. JW is an advisory board member of Abbott, Biogen, Boehringer Ingelheim, Immunogenetics, Lilly, MSD Sharp & Dohme, and Roche Pharma. JW received honoraria for lectures from the AGNP, Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., CSF-Society, Helios Klinikum Wuppertal, Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, Vitos Kurhessen-Bad Emstal, as well as funding from the German Federal Ministry for Education and Research (BMBF), the European Union (EU), and the German Research Foundation (DFG). JW holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945. CWM advises Janssen Cilag and LivaNova on an honorary basis. He advises the following hospitals and the hospital company: Amelung Klinik, hospital company: Mecklenburg-Vorpommern, Berlin-Brandenburg, Niedersachsen. CWM completes seminars for: mibeg institutes, PKM.

Figures

Fig. 1
Fig. 1
Medium-term and peri-pandemic course of psychosocial burden in patients with pre-existing mental disorders. A Course of the total sample (N = 156); differentiated by B gender (binary), N = 133; C ICD-10 F-axes (F2 to F8), N = 132; D ADNM-20 cut-off value indicating a high risk for adjustment disorder, N = 149; E psychiatric comorbidities: one vs. multiple F-diagnoses, N = 156.* p < 0.05, ** p < 0.01, *** p < 0.001. Mean values with 95%-CIs (A, B, D, E) and Bonferroni-corrected pairwise comparisons (A, B, D, E). Psychosocial burden is presented as mean of ratings on the 10-point Likert scales for psychosocial stress, psychiatric symptomatology, and quality of life. Ratings comprised pre-pandemic estimates (early 2020, retrospective rating), ratings very early during the pandemic/first lockdown (mid-March 2020, retrospective rating), at the end of the first lockdown (April/May 2020), and for the current state during the second lockdown (November/December 2020)
Fig. 2
Fig. 2
Medium-term and peri-pandemic course of symptom levels of adjustment disorder measured by the ADNM-20 in patients with pre-existing mental disorders, for T1 (1st lockdown, April/May 2020) and T2 (2nd lockdown, November/December 2020), A for the total sample (N = 152); differentiated by B gender (binary), N = 130; C ICD-10 F-axes (F2 to F8), N = 145; D psychiatric comorbidities: one vs. multiple F-diagnoses, N = 152. * p < 0.05, ** p < 0.01, *** p < 0.001. Mean values with 95% CIs and Bonferroni-corrected pairwise comparisons for the ADNM-20 sum score (range 20 to 80 points)

Comment in

References

    1. Kesner L, Horáček J. Three challenges that the COVID-19 pandemic represents for psychiatry. Br J Psychiatry. 2020;217:475–476. doi: 10.1192/bjp.2020.106. - DOI - PMC - PubMed
    1. Wang C, Pan R, Wan X, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020;87:40–48. doi: 10.1016/j.bbi.2020.04.028. - DOI - PMC - PubMed
    1. Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psych. 2020;33:e100213. doi: 10.1136/gpsych-2020-100213. - DOI - PMC - PubMed
    1. Li J, Yang Z, Qiu H, et al. Anxiety and depression among general population in China at the peak of the COVID-19 epidemic. World Psychiatry. 2020;19:249–250. doi: 10.1002/wps.20758. - DOI - PMC - PubMed
    1. Rossi R, Socci V, Talevi D, et al. COVID-19 pandemic and lockdown measures impact on mental health among the general population in Italy. Front Psychiatry. 2020 doi: 10.3389/fpsyt.2020.00790. - DOI - PMC - PubMed